The Stowers Institute for Medical Research has opened a commercial arm, BioMed Valley Discoveries, whose goal is to produce cures or biomedical advancements that can be used for new drugs, research or startup companies, the Kansas City Star reports.

“Our focus is on translating basic biomedical discoveries into applications that will improve human health,” said David Chao, president and chief executive officer of BioMed Valley Discoveries. Chao previously headed licensing and research agreements at the Novartis Institutes of Biomedical Research.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.